Distribuzione geografica
Continente #
NA - Nord America 2397
EU - Europa 1264
AS - Asia 123
AF - Africa 6
OC - Oceania 1
Totale 3791
Nazione #
US - Stati Uniti d'America 2389
PL - Polonia 405
IE - Irlanda 279
SE - Svezia 221
IT - Italia 162
AT - Austria 73
CN - Cina 50
JO - Giordania 45
FI - Finlandia 43
GB - Regno Unito 19
DE - Germania 15
UA - Ucraina 15
BE - Belgio 10
ES - Italia 9
CA - Canada 8
IN - India 8
TR - Turchia 8
VN - Vietnam 8
FR - Francia 5
SC - Seychelles 5
NL - Olanda 3
HK - Hong Kong 2
HR - Croazia 2
RU - Federazione Russa 2
AU - Australia 1
CZ - Repubblica Ceca 1
IR - Iran 1
JP - Giappone 1
MU - Mauritius 1
Totale 3791
Città #
Fairfield 438
Warsaw 404
Dublin 274
Chandler 246
Woodbridge 186
Ashburn 184
Cambridge 180
Seattle 165
Houston 158
Wilmington 151
Lawrence 100
Altamura 95
Ann Arbor 83
Princeton 79
Vienna 64
Medford 52
Beijing 44
Buffalo 34
Boston 33
San Diego 32
Jacksonville 18
Norwalk 13
Boardman 12
Falls Church 12
Florence 12
Barcelona 9
Brussels 9
Chennai 8
Dong Ket 8
Izmir 8
Milan 7
Frankfurt Am Main 5
London 4
Menlo Park 4
Toronto 4
Andover 3
Dearborn 3
Edmonton 3
Guangzhou 3
Philadelphia 3
Central 2
Chicago 2
Islington 2
Laurel 2
Phoenix 2
Prato 2
Reggio Emilia 2
Zagreb 2
Arezzo 1
Bari 1
Bremen 1
Cantagallo 1
Gloucester 1
Granarolo 1
Groningen 1
Grossmuehlingen 1
Helsinki 1
Kagoya 1
Kish 1
Leawood 1
Leuven 1
Lisburn 1
Livorno 1
Lonate Pozzolo 1
Los Angeles 1
Montréal 1
Nanjing 1
Palo Alto 1
Pisa 1
Poggibonsi 1
Pontedera 1
Portland 1
Rotterdam 1
San Mateo 1
Sesto Fiorentino 1
Siena 1
Sydney 1
Terracina 1
Torino 1
Turin 1
Verona 1
Totale 3199
Nome #
biologic therapy in children with enthesitis-related arthritis the fist year after disease onset 188
The intestinal microbiota in enthesitis-related arthitis 178
Alteration of Fecal Microbiota Profiles in Juvenile Idiopathic Arthritis. Associations with HLA-B27 Allele and Disease Status. 171
Superior efficacy of Adalimumab in treating childhood refractory chronic uveitis when used as first biologic modifier drug: Adalimumab as starting anti-TNF-alpha therapy in childhood chronic uveitis. 156
Serum amyloid A circulating levels and disease activity in patients with juvenile idiopathic arthritis. 114
Bone status of children born from mothers with autoimmune diseases treated during pregnancy with prednisone and/or low molecular weight heparin. 112
Immunosuppressive Activity of Abatacept on Circulating T Helper Lymphocytes from Juvenile Idiopathic Arthritis Patients 103
Anti-adalimumab antibodies in a cohort of patients with juvenile idiopathic arthritis: incidence and clinical correlations 98
Identification of autoantibodies against inner ear antigens in a cohort of children with idiopathic sensorineural hearing loss. 98
Oral clonidine provocative test in the diagnosis of growth hormone deficiency in childhood: should we make the timing uniform? 92
Glucocorticoids in the management of systemic juvenile idiopathic arthritis. 92
Clinical and transcriptional response to the long-acting interleukin-1 blocker canakinumab in Blau syndrome-related uveitis. 91
Early predictors of juvenile sacroiliitis in enthesitis-related arthritis. 89
Macrophage activation syndrome/Hemophagocytic Lymphohistiocytosis and Kawasaki disease. 86
Congenital heart block and immune mediated sensorineural hearing loss: possible cross reactivity of immune response 86
Difficult-To-Treat Juvenile Idiopathic Arthritis: Current and Future Options 83
Sequential MR angiography in childhood primary angiitis of the CNS. 83
Development and retrospective validation of the juvenile spondyloarthritis disease activity index. 77
Distal extremity pain as a presenting feature of Fabry's disease. 76
Clinical features and outcome of Cogan syndrome. 76
Successful treatment with canakinumab of a paediatric patient with resistant Behçet's disease 75
A peptide-based anti-Adalimumab antibody assay to monitor immune response to biologics treatment in juvenile idiopathic arthritis and childhood chronic non-infectious uveitis 70
Erratum to: Successful treatment with adalimumab for severe multifocal choroiditis and panuveitis in presumed (early-onset) ocular sarcoidosis 69
Utility of magnetic resonance imaging when following up sacroiliitis in enthesitis-related arthritis. 68
Treatment strategies for childhood noninfectious chronic uveitis: an update. 66
Surface plasmon resonance-based methodology for anti-adalimumab antibody identification and kinetic characterization 62
Distal limb pain as presenting feature of Fabry disease. 61
Superior efficacy of Adalimumab in treating childhood refractory chronic uveitis when used as first biologic modifier drug: Adalimumab as starting anti-TNF-α therapy in childhood chronic uveitis. 57
Elbow monoarthritis: an atypical onset of juvenile idiopathic arthritis. 55
What do cytokine profiles tell us about subsets of juvenile idiopathic arthritis? 52
Idiopathic Inflammatory Myopathies: an Update on Classification and Treatment with Special Focus on Juvenile Forms 48
The Development of Extra-Articular Manifestations in Children With Enthesitis-Related Arthritis: Natural Course or Different Disease Entity? 47
Clinical and Therapeutic Features of 312 Patients with Macrophage Activation Syndrome Enrolled in a Multinational Survey 46
AB1025 Chronic Recurrent Multifocal Osteomyelitis (CRMO): The Importance of an Accurate Differential Diagnosis 45
Diagnostic challenge of synovitis, acne, pustulosis, hyperostosis, and osteitis (SAPHO) syndrome in pediatric age: A monocentric case series 45
OBSIDIAn - real world evidence of Originator to BioSImilar Drug switch in juvenile idiopathic arthritis 42
Switching from Reference to Biosimilars Does Not Reduce Efficacy and Safety in Juvenile Idiopathic Arthritis 41
Circulating levels of vaspin and omentin, two novel adipokines, in juvenile idiopathic arthritis 40
Fast recovery of cardiac function in PIMS-TS patients early using intravenous anti-IL-1 treatment 39
Biological drugs in paediatric COVID-19 infection: what patients, which drug, how much and how long 39
Kawasaki disease 2013: Clinical cases and new issues 35
Cutaneous polyarteritis nodosa and common variable immunodeficiency: a previously unreported association. 35
Anti-Drug Antibodies Are Associated with Diminished Drug Levels and Treatment Failure 34
Cogan Syndrome: a rare but severe vasculitis in pediatric age 34
Early anti IL-1 treatment replaces steroids in refractory Kawasaki disease: clinical experience from two case reports 34
The off-label use of anakinra in pediatric systemic autoinflammatory diseases 34
Oral clonidine provocative test in the diagnosis of growth hormone deficiency (GHD) in childhood: should we make the timing uniform? 32
Increased percentages of tumor necrosisfactor-alpha+/interferon-gamma+ lymphocytes and calprotectin+/tumor necrosisfactor-alpha+ monocytes in patients with acute Kawasaki disease 31
 Possible Correlation Between Congenital Heart Block and Autoimmune Hearing Loss 29
Ocular involvement in monogenic autoinflammatory disease: A systematic literature review 28
Behçet syndrome in children and adults: discovering similarities and differences by a comparative study 27
Pathogenesis of Juvenile Idiopathic Arthritis: A Review of the Possible Role of Different Synovial Fluid T Lymphocyte Subsets 27
 A Rare Case of Neonatal Antiphospholipid Syndrome 27
Resistance to intravenous immunoglobulin (IVIG) in Kawasaki disease: no influence of different IVIG lot utilisation. 26
Cervical arthritis as early manifestation of enthesitis-related arthritis complicated by uveitis 26
Pathogenesis of juvenile idiopathic arthritis: A review of the possible role of different synovial fluid T lymphocyte subsets 26
Growth and body mass index in a cohort of patients with juvenile idiopathic arthritis: effects of second line treatments 25
Final height in females and males with precocious puberty after GnRHa treatment 24
Ineffectiveness of tumor necrosis factor-alpha inhibition in association with bisphosphonates for the treatment of cherubism. 22
Successful treatment of adalimumab in a child with Vogt-Koyanagi-Harada: which is the best available systemic treatment? 22
Sodium thiosulfate for the treatment of calcinosis secondary to juvenile dermatomyositis. 20
Usefulness of autoantibodies against inner ear antigens for the diagnosis 16
Increased percentages of tumor necrosis factor-alpha+/interferon-gamma+ T [corrected] lymphocytes and calprotectin+/tumor necrosis factor-alpha+ monocytes in patients with acute Kawasaki disease. 15
CD38high/HLA-DR+ CD8+ T cells as potential biomarker of hemophagocytic lymphohistiocytosis secondary to visceral Leishmania infection 11
STAT3-confusion-of-function: Beyond the loss and gain dualism 9
Totale 3891
Categoria #
all - tutte 7895
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 7895

Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2017/201844 0000 00 00 003014
2018/2019532 610149 219 99 1290178165
2019/2020846 85462964 9993 10099 93656112
2020/2021382 35372038 3735 1937 29571820
2021/2022518 4796934 812 1545 171768150
2022/20231293 1112765883 72214 21276 13516400
Totale 3891